Recent studies have indicated that IL-6, TNF-α, and IFN-γ were intensely elevated in COVID-19 patients and had become a significant feature of COVID-19 diseases deterioration (Diorio et al., 2020; Lucas et al., 2020; Karki et al., 2021). This evidence concerns the gene IL6 and COVID-19.